Improvement in the Anticancer Activity of 6-Mercaptopurine via Combination with Bismuth(III)
Authors:
- 1 January 2016
- journal article
- Published by Pharmaceutical Society of Japan
- Vol. 64 (11) , 1539-1545
Abstract
6-Mercaptopurine (6-MP) is a clinically important antitumor drug and its commercially available form is provided as monohydrate, belonging to biopharmaceuticals classification system (BCS) class II category. The combination of bismuth(III) (Bi(III)) with 6-MP was proved to significantly improve the anticancer activity of 6-MP, leading to the discovery of a new amorphous complex ([Bi(MP)3(NO3)2]NO3). The prepared [Bi(MP)3(NO3)2]NO3 was characterized by the matrix assisted laser desorption-ionization time-of-flight (MALDI-TOF)-MS, etc. Noticeably, according to the in vitro evaluations of cytotoxicity, cellular apoptotic, colony formation as well as cell migration, the anticancer activity of amorphous [Bi(MP)3(NO3)2]NO3 was found to be of high therapeutic effect over 6-MP.Keywords
This publication has 23 references indexed in Scilit:
- Arsenic Binding to ProteinsChemical Reviews, 2013
- A simple method for the preparation of PEG-6-mercaptopurine for oral administrationBioorganic & Medicinal Chemistry Letters, 2007
- Towards a Structural Understanding of the Anti‐Ulcer and Anti‐Gastritis Drug Bismuth SubsalicylateAngewandte Chemie International Edition, 2006
- Determination of mercaptopurine and its four metabolites by large‐volume sample stacking with polarity switching in capillary electrophoresisElectrophoresis, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl: Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)Journal of the American Chemical Society, 2003
- Antimony and bismuth compounds in oncologyCritical Reviews in Oncology/Hematology, 2002
- Amorphous pharmaceutical solids: preparation, characterization and stabilizationAdvanced Drug Delivery Reviews, 2001
- Bismuth Compounds and Preparations with Biological or Medicinal RelevanceChemical Reviews, 1999
- Enhanced Bioavailability of 6-Mercaptopurine After Rectal Administration in RatsPharmaceutical Research, 1992